Comparision of bupivacane versus ropivacaine with addition of dexmedetomidine in both in transverse abdominal plane block for post operative pain relief in lower abdominal surgery

Comparision of efficacy of bupivacaine with dexmedetomidine versus ropivacaine with dexmedetomidine for transversus abdominal plane block for post operative analgesia in patient undergoing lower abdominal surgery

Status

Recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/01/016955

Enrollment

Registered

2019-01-07

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K40-K46- Hernia

Interventions

Intervention1: 20 ml 0.25% Bupivacaine and 0.75 mcg/kg dexmedetomidine on each side: Transversus plane block Control Intervention1: 20 ml of 0.375% ropivacaine and 0.75 mcg/kg dexmedetomidine on each

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade-1&2 conscious & co-operative patent willing to participate

Exclusion criteria

Exclusion criteria: Age 70 years ASAgrade >3 pregnancy, morbid obesity, emergency surgery Refusal to participate

Design outcomes

Primary

Measure	Time frame
Comparision of efficacy of bupivacaine versus ropvacaine with addition of dexmedetomidine in both for post operative analesia in TAP blockTimepoint: 15 minute after extubation, 3o minute, hourly for first 4 hour,2nd hourly till 12 hour, 4th hourly till 24 hour	—

Secondary

Measure	Time frame
To look for any adverse effect of these drugTimepoint: Till 24 hours	—

Countries

India

Contacts

Public ContactDr Vinod Kr Verma

Indira gandhi institute of medical science, Patna

drvvinodv@gmail.com9709443785

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026